Login
← Go Back
Mankind Pharma
MANKIND · Pharma > Pharmaceuticals & Drugs Listing date: May 9, 2023
Stock Price vs Company Growth
1d
0.8%
1w
1.3%
1m
6.4%
3m
3.6%
6m
1.9%
1y
8.9%
all
35.0%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 2,577 0.8%
2,116
2,632
Company Overview
Sales
11,641 Cr
Growth: 14.8%
Profit after Tax
2,041 Cr
Growth: -3.5%
Large Cap
1,06,330 Cr
P/E: 50.6x
Industry P/E: 31.5x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals
Sales (Cr) ₹ 11,641
Growth 14.8%
EBITDA 25.4%
P/S 9.1x
Dividend 0.0%
P/E 50.6x
Book Value ₹ 265
PEG Ratio 3.4x
ROE 20.0%
P/B 9.6x
Shareholding Pattern
Increase    Decrease    No change
Company Profile Detailed
The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Belongs to (28 Indices) view more
Followers (2)
saurabh8...
varsha96